The aim of the study was to evaluate the changes of the plasma GLP−1 and GLP−2 levels before and during insulin treatment in diabetic ketoacidosis (DKA) which is a state characterized by extreme insulin deficiency. Here, INS is linked to diabetic ketoacidosis.